TACIVIEN Trademark

Trademark Overview

On Thursday, June 13, 2013, a trademark application was filed for TACIVIEN with the United States Patent and Trademark Office. The USPTO has given the TACIVIEN trademark a serial number of 85958886. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 21, 2015. This trademark is owned by Merck Sharp & Dohme Corp.. The TACIVIEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology
tacivien

General Information

Serial Number85958886
Word MarkTACIVIEN
Filing DateThursday, June 13, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 21, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 21, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Monday, September 21, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 21, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 16, 2015EXTENSION 2 GRANTED
Wednesday, January 28, 2015EXTENSION 2 FILED
Thursday, March 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 28, 2015TEAS EXTENSION RECEIVED
Wednesday, August 6, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 4, 2014EXTENSION 1 GRANTED
Monday, August 4, 2014EXTENSION 1 FILED
Monday, August 4, 2014TEAS EXTENSION RECEIVED
Tuesday, February 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 21, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 19, 2013ASSIGNED TO LIE
Wednesday, October 30, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 3, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 3, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 3, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 20, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 20, 2013NON-FINAL ACTION E-MAILED
Friday, September 20, 2013NON-FINAL ACTION WRITTEN
Friday, September 20, 2013REMOVED FROM TEAS PLUS
Thursday, September 19, 2013ASSIGNED TO EXAMINER
Friday, June 21, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 17, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

tacivien oncology preparations pharmaceutical